We are live on
!
Find out more
Iovance Biotherapeutics
IOVA
IOVA
167 hedge funds and large institutions have $3B invested in Iovance Biotherapeutics in 2019 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 54 increasing their positions, 40 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
983% more call options, than puts
Call options by funds: $20.5M | Put options by funds: $1.9M
168% more capital invested
Capital invested by funds: $1.12B → $3B (+$1.88B)
71% more funds holding in top 10
Funds holding in top 10: 7 → 12 (+5)
57% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 30
35% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 40
9% more funds holding
Funds holding: 153 → 167 (+14)
3.95% more ownership
Funds ownership: 95.06% → 99.01% (+3.9%)
Holders
167
Holders Change
+14
Holders Change %
+9.15%
% of All Funds
3.63%
Holding in Top 10
12
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+71.43%
% of All Funds
0.26%
New
47
Increased
54
Reduced
40
Closed
30
Calls
$20.5M
Puts
$1.9M
Net Calls
+$18.6M
Net Calls Change
+$17.5M
Top Buyers
| 1 |
CCM
Consonance Capital Management
New York
|
+$71M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$40.5M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$38.1M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$26.5M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$15.6M |
Top Sellers
| 1 |
BC
Broadfin Capital
New York
|
-$41.7M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$24.8M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$24.6M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$18.5M |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$15.1M |
